Latest filing published 05 Oct 2026 for ImmunityBio, Inc., €6.8M.
No signal scores available.
Simon Barry J. appears in our data through filings on ImmunityBio, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 4 June 2026 to 5 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 5 October 2026: a transaction of €6.8M, in ImmunityBio, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations